Faiz Kermani
Impact in
- Rheumatology top 5%
- Urticaria and Related Conditions
- Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Papers in
-
- Biotechnology and Related Fields 11
-
- Pharmaceutical Economics and Policy 5
- Co-authors
- A. KOBZA-BLACK (1 shared paper)R.K. Winkelmann (1 shared paper)B. F. O’Donnell (1 shared paper)David M. Francis (1 shared paper)Malcolm W. Greaves (1 shared paper)Michihiro Hide (1 shared paper)Robert M. Barr (1 shared paper)Melanie S. Flint (1 shared paper)
- Journals
- Drug Discovery Today (3 papers)Journal of Investigative Dermatology (1 paper)Toxicology and Applied Pharmacology (1 paper)BJOG An International Journal of Obstetrics & Gynaecology (1 paper)Eye (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Faiz Kermani
17 papers receiving 316 citations
Peers
Comparison fields: 5 of 69
- Rheumatology 233
- Genetics 90
- Pathology and Forensic Medicine 97
- Dermatology 48
- Immunology and Allergy 28
Countries citing papers authored by Faiz Kermani
This map shows the geographic impact of Faiz Kermani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faiz Kermani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faiz Kermani more than expected).
Fields of papers citing papers by Faiz Kermani
This network shows the impact of papers produced by Faiz Kermani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faiz Kermani. The network helps show where Faiz Kermani may publish in the future.
Co-authors
The 18 scholars most cited alongside Faiz Kermani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 254 | |
| 2 | 1999 | 23 | |
| 3 | 2000 | 22 | |
| 4 | 2023 | 9 | |
| 5 | 2003 | 7 | |
| 6 | 2003 | 7 | |
| 7 | 2006 | 4 | |
| 8 | 2004 | 3 | |
| 9 | 2006 | 3 | |
| 10 | 2005 | 3 | |
| 11 | 2009 | 3 | |
| 12 | Patient Compliance: Sweetening the Pill | 2006 | 3 |
| 13 | 2024 | 2 | |
| 14 | 2007 | 2 | |
| 15 | 2004 | 2 | |
| 16 | 2006 | 1 | |
| 17 | 2005 | 1 | |
| 18 | 2000 | 1 | |
| 19 | 2013 | 1 | |
| 20 | 2006 | 1 |
About Faiz Kermani
Faiz Kermani is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics, Biomedical Engineering, Physiology and Pharmacology, having authored 22 papers that have together received 352 indexed citations. Recurring topics across this work include Biotechnology and Related Fields (11 papers), Pharmaceutical Economics and Policy (5 papers), Biomedical and Engineering Education (4 papers), Biomedical Ethics and Regulation (3 papers), Science, Research, and Medicine (2 papers), Pharmaceutical industry and healthcare (2 papers), Intellectual Property and Patents (1 paper) and Contact Dermatitis and Allergies (1 paper). The work is most often cited by research in Rheumatology (233 citations), Genetics (90 citations), Pathology and Forensic Medicine (97 citations), Dermatology (48 citations) and Immunology and Allergy (28 citations). Faiz Kermani has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include A. KOBZA-BLACK, R.K. Winkelmann, B. F. O’Donnell, David M. Francis, Malcolm W. Greaves, Michihiro Hide, Robert M. Barr, Melanie S. Flint, Sharon A.M. Hotchkiss and Rachel M. Tribe. Their work appears in journals such as Drug Discovery Today, Journal of Investigative Dermatology, Toxicology and Applied Pharmacology, BJOG An International Journal of Obstetrics & Gynaecology and Eye.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.